α1プロテアーゼ阻害剤の世界市場レポート2024-2030
英文タイトル: Global Alpha-1 Proteinase Inhibitor Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、α1プロテアーゼ阻害剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にα1プロテアーゼ阻害剤市場を分類しています。本レポートでは世界のα1プロテアーゼ阻害剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Takeda、Kamada、Grifols、CSL Behring
レポートはα1プロテアーゼ阻害剤の主要生産者を調査し、主要地域や国の消費状況も提供します。α1プロテアーゼ阻害剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント:
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別(地域レベル、国レベル)のα1プロテアーゼ阻害剤生産量、成長率、市場シェアを調査している。
Solution
Powder
用途別の市場セグメント:
Hospital
Clinic
本レポートの詳細内容
本レポートは、世界のα1プロテアーゼ阻害剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてα1プロテアーゼ阻害剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、α1プロテアーゼ阻害剤の売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。
三.主要メーカーのα1プロテアーゼ阻害剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のα1プロテアーゼ阻害剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本α1プロテアーゼ阻害剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章:α1プロテアーゼ阻害剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(2019~2030)
第2章: α1プロテアーゼ阻害剤の世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(2019~2030)
第3章:世界、地域、国レベルにおけるα1プロテアーゼ阻害剤の売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(2019~2030)
第4章α1プロテアーゼ阻害剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(2019~2024)
第5章:α1プロテアーゼ阻害剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(2019~2030)
第9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(2019~2030)
第10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(2019~2030)
第11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第12章:α1プロテアーゼ阻害剤の主要メーカーの概要を提供し、製品の説明と仕様、α1プロテアーゼ阻害剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(2019~2024)
第13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章:α1プロテアーゼ阻害剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章:レポートの要点と結論。
概要
Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation. The global Alpha-1 Proteinase Inhibitor market is projected to grow from US$ 229 million in 2024 to US$ 293.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The market growth can be attributed to several factors. Firstly, increasing awareness and improved diagnosis of AATD have led to a better identification of patients with this condition, driving the demand for Alpha1-PI therapy. Additionally, advancements in biotechnology and protein manufacturing techniques have contributed to the development of highly purified and more effective Alpha1-PI products, offering improved treatment options for patients. Report Covers: This report presents an overview of global market for Alpha-1 Proteinase Inhibitor, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Alpha-1 Proteinase Inhibitor, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Alpha-1 Proteinase Inhibitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Alpha-1 Proteinase Inhibitor sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Alpha-1 Proteinase Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Alpha-1 Proteinase Inhibitor sales, projected growth trends, production technology, application and end-user industry. Market Segmentation By Company Takeda Kamada Grifols CSL Behring Segment by Type Solution Powder Segment by Application Hospital Clinic Segment by Region US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Europe Germany France U.K. Italy Russia Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Sales (consumption), revenue of Alpha-1 Proteinase Inhibitor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 3: Detailed analysis of Alpha-1 Proteinase Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment. Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment. Chapter 8: China by Type, and by Application, sales, and revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment. Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alpha-1 Proteinase Inhibitor sales, revenue, price, gross margin, and recent development, etc. Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers. Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 14: The main points and conclusions of the report.
総目録
1 Study Coverage
1.1 Alpha-1 Proteinase Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Alpha-1 Proteinase Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Solution
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Alpha-1 Proteinase Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Alpha-1 Proteinase Inhibitor Sales Estimates and Forecasts 2019-2030
2.2 Global Alpha-1 Proteinase Inhibitor Revenue by Region
2.2.1 Global Alpha-1 Proteinase Inhibitor Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Alpha-1 Proteinase Inhibitor Revenue by Region (2019-2024)
2.2.3 Global Alpha-1 Proteinase Inhibitor Revenue by Region (2025-2030)
2.2.4 Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Region (2019-2030)
2.3 Global Alpha-1 Proteinase Inhibitor Sales Estimates and Forecasts 2019-2030
2.4 Global Alpha-1 Proteinase Inhibitor Sales by Region
2.4.1 Global Alpha-1 Proteinase Inhibitor Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Alpha-1 Proteinase Inhibitor Sales by Region (2019-2024)
2.4.3 Global Alpha-1 Proteinase Inhibitor Sales by Region (2025-2030)
2.4.4 Global Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Alpha-1 Proteinase Inhibitor Sales by Manufacturers
3.1.1 Global Alpha-1 Proteinase Inhibitor Sales by Manufacturers (2019-2024)
3.1.2 Global Alpha-1 Proteinase Inhibitor Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alpha-1 Proteinase Inhibitor in 2023
3.2 Global Alpha-1 Proteinase Inhibitor Revenue by Manufacturers
3.2.1 Global Alpha-1 Proteinase Inhibitor Revenue by Manufacturers (2019-2024)
3.2.2 Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Alpha-1 Proteinase Inhibitor Revenue in 2023
3.3 Global Key Players of Alpha-1 Proteinase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Alpha-1 Proteinase Inhibitor Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Alpha-1 Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Alpha-1 Proteinase Inhibitor, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Alpha-1 Proteinase Inhibitor, Product Offered and Application
3.8 Global Key Manufacturers of Alpha-1 Proteinase Inhibitor, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Alpha-1 Proteinase Inhibitor Sales by Type
4.1.1 Global Alpha-1 Proteinase Inhibitor Historical Sales by Type (2019-2024)
4.1.2 Global Alpha-1 Proteinase Inhibitor Forecasted Sales by Type (2025-2030)
4.1.3 Global Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2019-2030)
4.2 Global Alpha-1 Proteinase Inhibitor Revenue by Type
4.2.1 Global Alpha-1 Proteinase Inhibitor Historical Revenue by Type (2019-2024)
4.2.2 Global Alpha-1 Proteinase Inhibitor Forecasted Revenue by Type (2025-2030)
4.2.3 Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2019-2030)
4.3 Global Alpha-1 Proteinase Inhibitor Price by Type
4.3.1 Global Alpha-1 Proteinase Inhibitor Price by Type (2019-2024)
4.3.2 Global Alpha-1 Proteinase Inhibitor Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Alpha-1 Proteinase Inhibitor Sales by Application
5.1.1 Global Alpha-1 Proteinase Inhibitor Historical Sales by Application (2019-2024)
5.1.2 Global Alpha-1 Proteinase Inhibitor Forecasted Sales by Application (2025-2030)
5.1.3 Global Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2019-2030)
5.2 Global Alpha-1 Proteinase Inhibitor Revenue by Application
5.2.1 Global Alpha-1 Proteinase Inhibitor Historical Revenue by Application (2019-2024)
5.2.2 Global Alpha-1 Proteinase Inhibitor Forecasted Revenue by Application (2025-2030)
5.2.3 Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2019-2030)
5.3 Global Alpha-1 Proteinase Inhibitor Price by Application
5.3.1 Global Alpha-1 Proteinase Inhibitor Price by Application (2019-2024)
5.3.2 Global Alpha-1 Proteinase Inhibitor Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Alpha-1 Proteinase Inhibitor Market Size by Type
6.1.1 US & Canada Alpha-1 Proteinase Inhibitor Sales by Type (2019-2030)
6.1.2 US & Canada Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2030)
6.2 US & Canada Alpha-1 Proteinase Inhibitor Market Size by Application
6.2.1 US & Canada Alpha-1 Proteinase Inhibitor Sales by Application (2019-2030)
6.2.2 US & Canada Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2030)
6.3 US & Canada Alpha-1 Proteinase Inhibitor Market Size by Country
6.3.1 US & Canada Alpha-1 Proteinase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Alpha-1 Proteinase Inhibitor Sales by Country (2019-2030)
6.3.3 US & Canada Alpha-1 Proteinase Inhibitor Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Alpha-1 Proteinase Inhibitor Market Size by Type
7.1.1 Europe Alpha-1 Proteinase Inhibitor Sales by Type (2019-2030)
7.1.2 Europe Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2030)
7.2 Europe Alpha-1 Proteinase Inhibitor Market Size by Application
7.2.1 Europe Alpha-1 Proteinase Inhibitor Sales by Application (2019-2030)
7.2.2 Europe Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2030)
7.3 Europe Alpha-1 Proteinase Inhibitor Market Size by Country
7.3.1 Europe Alpha-1 Proteinase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Alpha-1 Proteinase Inhibitor Sales by Country (2019-2030)
7.3.3 Europe Alpha-1 Proteinase Inhibitor Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Alpha-1 Proteinase Inhibitor Market Size
8.1.1 China Alpha-1 Proteinase Inhibitor Sales (2019-2030)
8.1.2 China Alpha-1 Proteinase Inhibitor Revenue (2019-2030)
8.2 China Alpha-1 Proteinase Inhibitor Market Size by Application
8.2.1 China Alpha-1 Proteinase Inhibitor Sales by Application (2019-2030)
8.2.2 China Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Alpha-1 Proteinase Inhibitor Market Size by Type
9.1.1 Asia Alpha-1 Proteinase Inhibitor Sales by Type (2019-2030)
9.1.2 Asia Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2030)
9.2 Asia Alpha-1 Proteinase Inhibitor Market Size by Application
9.2.1 Asia Alpha-1 Proteinase Inhibitor Sales by Application (2019-2030)
9.2.2 Asia Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2030)
9.3 Asia Alpha-1 Proteinase Inhibitor Sales by Region
9.3.1 Asia Alpha-1 Proteinase Inhibitor Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Alpha-1 Proteinase Inhibitor Revenue by Region (2019-2030)
9.3.3 Asia Alpha-1 Proteinase Inhibitor Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Market Size by Type
10.1.1 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Market Size by Application
10.2.1 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Country
10.3.1 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Alpha-1 Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Takeda Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Kamada
11.2.1 Kamada Company Information
11.2.2 Kamada Overview
11.2.3 Kamada Alpha-1 Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Kamada Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Kamada Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Alpha-1 Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Grifols Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 CSL Behring
11.4.1 CSL Behring Company Information
11.4.2 CSL Behring Overview
11.4.3 CSL Behring Alpha-1 Proteinase Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 CSL Behring Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CSL Behring Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Alpha-1 Proteinase Inhibitor Industry Chain Analysis
12.2 Alpha-1 Proteinase Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Alpha-1 Proteinase Inhibitor Production Mode & Process
12.4 Alpha-1 Proteinase Inhibitor Sales and Marketing
12.4.1 Alpha-1 Proteinase Inhibitor Sales Channels
12.4.2 Alpha-1 Proteinase Inhibitor Distributors
12.5 Alpha-1 Proteinase Inhibitor Customers
13 Market Dynamics
13.1 Alpha-1 Proteinase Inhibitor Industry Trends
13.2 Alpha-1 Proteinase Inhibitor Market Drivers
13.3 Alpha-1 Proteinase Inhibitor Market Challenges
13.4 Alpha-1 Proteinase Inhibitor Market Restraints
14 Key Findings in The Global Alpha-1 Proteinase Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
表と図のリスト
List of Tables Table 1. Global Alpha-1 Proteinase Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Table 2. Major Manufacturers of Solution Table 3. Major Manufacturers of Powder Table 4. Global Alpha-1 Proteinase Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Table 5. Global Alpha-1 Proteinase Inhibitor Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 6. Global Alpha-1 Proteinase Inhibitor Revenue by Region (2019-2024) & (US$ Million) Table 7. Global Alpha-1 Proteinase Inhibitor Revenue by Region (2025-2030) & (US$ Million) Table 8. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Region (2019-2024) Table 9. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Region (2025-2030) Table 10. Global Alpha-1 Proteinase Inhibitor Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 11. Global Alpha-1 Proteinase Inhibitor Sales by Region (2019-2024) & (K Units) Table 12. Global Alpha-1 Proteinase Inhibitor Sales by Region (2025-2030) & (K Units) Table 13. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2019-2024) Table 14. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2025-2030) Table 15. Global Alpha-1 Proteinase Inhibitor Sales by Manufacturers (2019-2024) & (K Units) Table 16. Global Alpha-1 Proteinase Inhibitor Sales Share by Manufacturers (2019-2024) Table 17. Global Alpha-1 Proteinase Inhibitor Revenue by Manufacturers (2019-2024) & (US$ Million) Table 18. Global Alpha-1 Proteinase Inhibitor Revenue Share by Manufacturers (2019-2024) Table 19. Global Key Players of Alpha-1 Proteinase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024 Table 20. Alpha-1 Proteinase Inhibitor Price by Manufacturers 2019-2024 (US$/Unit) Table 21. Global Alpha-1 Proteinase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Alpha-1 Proteinase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Proteinase Inhibitor as of 2023) Table 23. Global Key Manufacturers of Alpha-1 Proteinase Inhibitor, Manufacturing Base Distribution and Headquarters Table 24. Global Key Manufacturers of Alpha-1 Proteinase Inhibitor, Product Offered and Application Table 25. Global Key Manufacturers of Alpha-1 Proteinase Inhibitor, Date of Enter into This Industry Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Alpha-1 Proteinase Inhibitor Sales by Type (2019-2024) & (K Units) Table 28. Global Alpha-1 Proteinase Inhibitor Sales by Type (2025-2030) & (K Units) Table 29. Global Alpha-1 Proteinase Inhibitor Sales Share by Type (2019-2024) Table 30. Global Alpha-1 Proteinase Inhibitor Sales Share by Type (2025-2030) Table 31. Global Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2024) & (US$ Million) Table 32. Global Alpha-1 Proteinase Inhibitor Revenue by Type (2025-2030) & (US$ Million) Table 33. Global Alpha-1 Proteinase Inhibitor Revenue Share by Type (2019-2024) Table 34. Global Alpha-1 Proteinase Inhibitor Revenue Share by Type (2025-2030) Table 35. Alpha-1 Proteinase Inhibitor Price by Type (2019-2024) & (US$/Unit) Table 36. Global Alpha-1 Proteinase Inhibitor Price Forecast by Type (2025-2030) & (US$/Unit) Table 37. Global Alpha-1 Proteinase Inhibitor Sales by Application (2019-2024) & (K Units) Table 38. Global Alpha-1 Proteinase Inhibitor Sales by Application (2025-2030) & (K Units) Table 39. Global Alpha-1 Proteinase Inhibitor Sales Share by Application (2019-2024) Table 40. Global Alpha-1 Proteinase Inhibitor Sales Share by Application (2025-2030) Table 41. Global Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2024) & (US$ Million) Table 42. Global Alpha-1 Proteinase Inhibitor Revenue by Application (2025-2030) & (US$ Million) Table 43. Global Alpha-1 Proteinase Inhibitor Revenue Share by Application (2019-2024) Table 44. Global Alpha-1 Proteinase Inhibitor Revenue Share by Application (2025-2030) Table 45. Alpha-1 Proteinase Inhibitor Price by Application (2019-2024) & (US$/Unit) Table 46. Global Alpha-1 Proteinase Inhibitor Price Forecast by Application (2025-2030) & (US$/Unit) Table 47. US & Canada Alpha-1 Proteinase Inhibitor Sales by Type (2019-2024) & (K Units) Table 48. US & Canada Alpha-1 Proteinase Inhibitor Sales by Type (2025-2030) & (K Units) Table 49. US & Canada Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2024) & (US$ Million) Table 50. US & Canada Alpha-1 Proteinase Inhibitor Revenue by Type (2025-2030) & (US$ Million) Table 51. US & Canada Alpha-1 Proteinase Inhibitor Sales by Application (2019-2024) & (K Units) Table 52. US & Canada Alpha-1 Proteinase Inhibitor Sales by Application (2025-2030) & (K Units) Table 53. US & Canada Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2024) & (US$ Million) Table 54. US & Canada Alpha-1 Proteinase Inhibitor Revenue by Application (2025-2030) & (US$ Million) Table 55. US & Canada Alpha-1 Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 56. US & Canada Alpha-1 Proteinase Inhibitor Revenue by Country (2019-2024) & (US$ Million) Table 57. US & Canada Alpha-1 Proteinase Inhibitor Revenue by Country (2025-2030) & (US$ Million) Table 58. US & Canada Alpha-1 Proteinase Inhibitor Sales by Country (2019-2024) & (K Units) Table 59. US & Canada Alpha-1 Proteinase Inhibitor Sales by Country (2025-2030) & (K Units) Table 60. Europe Alpha-1 Proteinase Inhibitor Sales by Type (2019-2024) & (K Units) Table 61. Europe Alpha-1 Proteinase Inhibitor Sales by Type (2025-2030) & (K Units) Table 62. Europe Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2024) & (US$ Million) Table 63. Europe Alpha-1 Proteinase Inhibitor Revenue by Type (2025-2030) & (US$ Million) Table 64. Europe Alpha-1 Proteinase Inhibitor Sales by Application (2019-2024) & (K Units) Table 65. Europe Alpha-1 Proteinase Inhibitor Sales by Application (2025-2030) & (K Units) Table 66. Europe Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2024) & (US$ Million) Table 67. Europe Alpha-1 Proteinase Inhibitor Revenue by Application (2025-2030) & (US$ Million) Table 68. Europe Alpha-1 Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 69. Europe Alpha-1 Proteinase Inhibitor Revenue by Country (2019-2024) & (US$ Million) Table 70. Europe Alpha-1 Proteinase Inhibitor Revenue by Country (2025-2030) & (US$ Million) Table 71. Europe Alpha-1 Proteinase Inhibitor Sales by Country (2019-2024) & (K Units) Table 72. Europe Alpha-1 Proteinase Inhibitor Sales by Country (2025-2030) & (K Units) Table 73. China Alpha-1 Proteinase Inhibitor Sales by Type (2019-2024) & (K Units) Table 74. China Alpha-1 Proteinase Inhibitor Sales by Type (2025-2030) & (K Units) Table 75. China Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2024) & (US$ Million) Table 76. China Alpha-1 Proteinase Inhibitor Revenue by Type (2025-2030) & (US$ Million) Table 77. China Alpha-1 Proteinase Inhibitor Sales by Application (2019-2024) & (K Units) Table 78. China Alpha-1 Proteinase Inhibitor Sales by Application (2025-2030) & (K Units) Table 79. China Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2024) & (US$ Million) Table 80. China Alpha-1 Proteinase Inhibitor Revenue by Application (2025-2030) & (US$ Million) Table 81. Asia Alpha-1 Proteinase Inhibitor Sales by Type (2019-2024) & (K Units) Table 82. Asia Alpha-1 Proteinase Inhibitor Sales by Type (2025-2030) & (K Units) Table 83. Asia Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2024) & (US$ Million) Table 84. Asia Alpha-1 Proteinase Inhibitor Revenue by Type (2025-2030) & (US$ Million) Table 85. Asia Alpha-1 Proteinase Inhibitor Sales by Application (2019-2024) & (K Units) Table 86. Asia Alpha-1 Proteinase Inhibitor Sales by Application (2025-2030) & (K Units) Table 87. Asia Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2024) & (US$ Million) Table 88. Asia Alpha-1 Proteinase Inhibitor Revenue by Application (2025-2030) & (US$ Million) Table 89. Asia Alpha-1 Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 90. Asia Alpha-1 Proteinase Inhibitor Revenue by Region (2019-2024) & (US$ Million) Table 91. Asia Alpha-1 Proteinase Inhibitor Revenue by Region (2025-2030) & (US$ Million) Table 92. Asia Alpha-1 Proteinase Inhibitor Sales by Region (2019-2024) & (K Units) Table 93. Asia Alpha-1 Proteinase Inhibitor Sales by Region (2025-2030) & (K Units) Table 94. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Type (2019-2024) & (K Units) Table 95. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Type (2025-2030) & (K Units) Table 96. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Type (2019-2024) & (US$ Million) Table 97. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Type (2025-2030) & (US$ Million) Table 98. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Application (2019-2024) & (K Units) Table 99. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Application (2025-2030) & (K Units) Table 100. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Application (2019-2024) & (US$ Million) Table 101. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Application (2025-2030) & (US$ Million) Table 102. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 103. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Country (2019-2024) & (US$ Million) Table 104. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue by Country (2025-2030) & (US$ Million) Table 105. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Country (2019-2024) & (K Units) Table 106. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales by Country (2025-2030) & (K Units) Table 107. Takeda Company Information Table 108. Takeda Description and Major Businesses Table 109. Takeda Alpha-1 Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 110. Takeda Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications Table 111. Takeda Recent Developments Table 112. Kamada Company Information Table 113. Kamada Description and Major Businesses Table 114. Kamada Alpha-1 Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 115. Kamada Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Kamada Recent Developments Table 117. Grifols Company Information Table 118. Grifols Description and Major Businesses Table 119. Grifols Alpha-1 Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 120. Grifols Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Grifols Recent Developments Table 122. CSL Behring Company Information Table 123. CSL Behring Description and Major Businesses Table 124. CSL Behring Alpha-1 Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 125. CSL Behring Alpha-1 Proteinase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications Table 126. CSL Behring Recent Developments Table 127. Key Raw Materials Lists Table 128. Raw Materials Key Suppliers Lists Table 129. Alpha-1 Proteinase Inhibitor Distributors List Table 130. Alpha-1 Proteinase Inhibitor Customers List Table 131. Alpha-1 Proteinase Inhibitor Market Trends Table 132. Alpha-1 Proteinase Inhibitor Market Drivers Table 133. Alpha-1 Proteinase Inhibitor Market Challenges Table 134. Alpha-1 Proteinase Inhibitor Market Restraints Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Alpha-1 Proteinase Inhibitor Product Picture Figure 2. Global Alpha-1 Proteinase Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Alpha-1 Proteinase Inhibitor Market Share by Type in 2023 & 2030 Figure 4. Solution Product Picture Figure 5. Powder Product Picture Figure 6. Global Alpha-1 Proteinase Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 7. Global Alpha-1 Proteinase Inhibitor Market Share by Application in 2023 & 2030 Figure 8. Hospital Figure 9. Clinic Figure 10. Alpha-1 Proteinase Inhibitor Report Years Considered Figure 11. Global Alpha-1 Proteinase Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 12. Global Alpha-1 Proteinase Inhibitor Revenue 2019-2030 (US$ Million) Figure 13. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Region in Percentage: 2023 Versus 2030 Figure 14. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Region (2019-2030) Figure 15. Global Alpha-1 Proteinase Inhibitor Sales 2019-2030 ((K Units) Figure 16. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Region (2019-2030) Figure 17. US & Canada Alpha-1 Proteinase Inhibitor Sales YoY (2019-2030) & (K Units) Figure 18. US & Canada Alpha-1 Proteinase Inhibitor Revenue YoY (2019-2030) & (US$ Million) Figure 19. Europe Alpha-1 Proteinase Inhibitor Sales YoY (2019-2030) & (K Units) Figure 20. Europe Alpha-1 Proteinase Inhibitor Revenue YoY (2019-2030) & (US$ Million) Figure 21. China Alpha-1 Proteinase Inhibitor Sales YoY (2019-2030) & (K Units) Figure 22. China Alpha-1 Proteinase Inhibitor Revenue YoY (2019-2030) & (US$ Million) Figure 23. Asia (excluding China) Alpha-1 Proteinase Inhibitor Sales YoY (2019-2030) & (K Units) Figure 24. Asia (excluding China) Alpha-1 Proteinase Inhibitor Revenue YoY (2019-2030) & (US$ Million) Figure 25. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales YoY (2019-2030) & (K Units) Figure 26. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue YoY (2019-2030) & (US$ Million) Figure 27. The Alpha-1 Proteinase Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023 Figure 28. The Top 5 and 10 Largest Manufacturers of Alpha-1 Proteinase Inhibitor in the World: Market Share by Alpha-1 Proteinase Inhibitor Revenue in 2023 Figure 29. Global Alpha-1 Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 30. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2019-2030) Figure 31. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2019-2030) Figure 32. Global Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2019-2030) Figure 33. Global Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2019-2030) Figure 34. US & Canada Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2019-2030) Figure 35. US & Canada Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2019-2030) Figure 36. US & Canada Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2019-2030) Figure 37. US & Canada Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2019-2030) Figure 38. US & Canada Alpha-1 Proteinase Inhibitor Revenue Share by Country (2019-2030) Figure 39. US & Canada Alpha-1 Proteinase Inhibitor Sales Share by Country (2019-2030) Figure 40. U.S. Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 41. Canada Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 42. Europe Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2019-2030) Figure 43. Europe Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2019-2030) Figure 44. Europe Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2019-2030) Figure 45. Europe Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2019-2030) Figure 46. Europe Alpha-1 Proteinase Inhibitor Revenue Share by Country (2019-2030) Figure 47. Europe Alpha-1 Proteinase Inhibitor Sales Share by Country (2019-2030) Figure 48. Germany Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 49. France Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 50. U.K. Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 51. Italy Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 52. Russia Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 53. China Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2019-2030) Figure 54. China Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2019-2030) Figure 55. China Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2019-2030) Figure 56. China Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2019-2030) Figure 57. Asia Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2019-2030) Figure 58. Asia Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2019-2030) Figure 59. Asia Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2019-2030) Figure 60. Asia Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2019-2030) Figure 61. Asia Alpha-1 Proteinase Inhibitor Revenue Share by Region (2019-2030) Figure 62. Asia Alpha-1 Proteinase Inhibitor Sales Share by Region (2019-2030) Figure 63. Japan Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 64. South Korea Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 65. China Taiwan Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 66. Southeast Asia Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 67. India Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 68. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales Market Share by Type (2019-2030) Figure 69. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue Market Share by Type (2019-2030) Figure 70. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales Market Share by Application (2019-2030) Figure 71. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue Market Share by Application (2019-2030) Figure 72. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Revenue Share by Country (2019-2030) Figure 73. Middle East, Africa and Latin America Alpha-1 Proteinase Inhibitor Sales Share by Country (2019-2030) Figure 74. Brazil Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 75. Mexico Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 76. Turkey Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 77. Israel Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 78. GCC Countries Alpha-1 Proteinase Inhibitor Revenue (2019-2030) & (US$ Million) Figure 79. Alpha-1 Proteinase Inhibitor Value Chain Figure 80. Alpha-1 Proteinase Inhibitor Production Process Figure 81. Channels of Distribution Figure 82. Distributors Profiles Figure 83. Bottom-up and Top-down Approaches for This Report Figure 84. Data Triangulation Figure 85. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)